Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.
2.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Clarke MS, Sim EH, Fong KM.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002991. doi: 10.1002/14651858.CD002991.pub3. Review.

PMID:
22786484
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL.

Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.

PMID:
17975187
5.

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Ann Intern Med. 2009 Oct 20;151(8):517-27.

PMID:
19841453
6.
7.

Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.

Terzano C, Petroianni A, Ricci A, Allegra L.

Eur Rev Med Pharmacol Sci. 2005 Jul-Aug;9(4):209-15.

PMID:
16128040
8.

The place of inhaled corticosteroids in chronic obstructive pulmonary disease.

Selroos O.

Curr Med Res Opin. 2004 Oct;20(10):1579-93. Review.

PMID:
15462691
9.

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.

Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.

Thorax. 2005 Jun;60(6):480-7.

10.

Steroid therapy in chronic obstructive pulmonary disease.

OBrien A, Ward NS.

Med Health R I. 2002 Feb;85(2):52-5.

PMID:
11881166
11.

Inhaled steroid therapy in chronic obstructive pulmonary disease.

Whittaker AJ, Spiro SG.

Curr Opin Pulm Med. 2000 Mar;6(2):104-9. Review.

PMID:
10741768
12.

[Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].

Ieda Y, Nagasaka Y.

Clin Calcium. 2007 Jun;17(6):955-62. Review. Japanese.

PMID:
17548937
13.

[Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].

Bridevaux PO, Leuenberger P.

Rev Med Suisse. 2005 Nov 16;1(41):2673-4, 2677-9. Review. French.

PMID:
16355882
14.
15.
16.

Effective management of COPD in primary care - the role of long-acting beta agonist/inhaled corticosteroid combination therapy.

van Schayck CP, Reid J.

Prim Care Respir J. 2006 Jun;15(3):143-51. Epub 2006 Apr 11. Review.

17.
18.

Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.

Anzueto A.

Am J Med. 2006 Oct;119(10 Suppl 1):46-53. Review.

PMID:
16996899
19.

Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis.

Highland KB, Strange C, Heffner JE.

Ann Intern Med. 2003 Jun 17;138(12):969-73. Erratum in: Ann Intern Med. 2003 Nov 18;139(10):873.

PMID:
12809453
20.

[The choice and administration of corticoids in COPD].

Yernault JC, Sternon J.

Rev Med Brux. 2002 Apr;23(2):96-101. Review. French.

PMID:
12056065

Supplemental Content

Support Center